Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile



Phone: n/a Fax: n/a


AbbVie (NYSE:ABBV) is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. AbbVie employs approximately 25,000 people worldwide and markets medicines in more than 170 countries.

 Key Statistics

Ownership: Public

Web Site: AbbVie
Symbol: ABBV


 Company News
ISI Group: AbbVie (ABBV)’s Dividend, Repurchasing Attempt Could Mean More Debt 10/21/2014 1:43:58 PM
AbbVie (ABBV) Announces New $5 Billion Stock Repurchase Program And Increases Dividend 10/21/2014 7:51:46 AM
AbbVie (ABBV) Officially Abandons Shire 10/21/2014 5:27:55 AM
Enanta Pharmaceuticals, Inc. Rejects HCV Drug Co-Development Option With AbbVie (ABBV) 10/20/2014 7:41:24 PM
Shire Goes Shopping After AbbVie (ABBV) Deal Falls Through 10/19/2014 2:40:57 PM
AbbVie (ABBV) Still A Buy Despite Shire Fallout, Says Analyst 10/17/2014 11:39:27 AM
Here’s What An AbbVie (ABBV)-Shire Split Might Mean For Massachusetts 10/17/2014 6:40:14 AM
AbbVie (ABBV) Board Officially Abandons $55 Billion Shire Merger 10/16/2014 5:57:28 AM
Shire Plummets As AbbVie (ABBV) Reconsiders $55 Billion Takeover Bid 10/15/2014 5:56:03 AM
AbbVie (ABBV) Announces Late-Breaking Results From Phase 3 Trial Of HUMIRA® (Adalimumab) In Hidradenitis Suppurativa (HS) Patients At The European Academy Of Dermatology And Venereology Congress 10/13/2014 8:02:31 AM